NasdaqGS - Delayed Quote • USD
AbCellera Biologics Inc. (ABCL)
At close: April 25 at 4:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BOOTH ANDREW Chief Financial Officer | Purchase | May 26, 2023 | 283,959 |
| FALCONER ESTER Chief Technology Officer | Conversion of Exercise of derivative security | Sep 1, 2021 | 875,000 |
| HAMER JOHN Director | Sale | Sep 1, 2021 | 14,734,600 |
| HANSEN CARL L.G. Chief Executive Officer | Conversion of Exercise of derivative security | Feb 26, 2024 | 56,532,100 |
| HAYDEN MICHAEL REUBEN Director | Purchase | Sep 22, 2023 | -- |
| LECAULT VERONIQUE Chief Operating Officer | Purchase | Sep 12, 2023 | 9,530,340 |
| MONTALBANO JOHN S. Director | Purchase | Nov 8, 2023 | 91,000 |
| STIMART TRYN J.D. Officer | Sale | Jun 9, 2021 | 500 |
| THERMOPYLAE HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security | Stock Gift | Dec 19, 2023 | 55,802,500 |
| THIEL PETER A. J.D. Director | Purchase | Dec 15, 2020 | -- |
Related Tickers
NTLA Intellia Therapeutics, Inc.
20.02
-5.43%
DNA Ginkgo Bioworks Holdings, Inc.
0.7777
-8.05%
BEAM Beam Therapeutics Inc.
21.60
-5.01%
ADPT Adaptive Biotechnologies Corporation
2.6100
+0.38%
RXRX Recursion Pharmaceuticals, Inc.
7.84
-1.26%
EDIT Editas Medicine, Inc.
5.22
-2.43%
CRBU Caribou Biosciences, Inc.
3.7600
-2.34%
CRSP CRISPR Therapeutics AG
53.73
-3.45%
BLUE bluebird bio, Inc.
0.9125
-1.13%
PRME Prime Medicine, Inc.
4.3000
-8.51%